KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cardinal Health (CAH) EBITDA (2016 - 2025)

Cardinal Health's EBITDA history spans 17 years, with the latest figure at $707.0 million for Q4 2025.

  • For Q4 2025, EBITDA rose 28.78% year-over-year to $707.0 million; the TTM value through Dec 2025 reached $2.5 billion, up 33.74%, while the annual FY2025 figure was $2.3 billion, 83.02% up from the prior year.
  • EBITDA for Q4 2025 was $707.0 million at Cardinal Health, up from $668.0 million in the prior quarter.
  • Across five years, EBITDA topped out at $730.0 million in Q1 2025 and bottomed at -$950.0 million in Q4 2021.
  • The 5-year median for EBITDA is $411.5 million (2021), against an average of $284.0 million.
  • The largest annual shift saw EBITDA tumbled 306.07% in 2021 before it soared 1875.0% in 2024.
  • A 5-year view of EBITDA shows it stood at -$950.0 million in 2021, then soared by 87.47% to -$119.0 million in 2022, then skyrocketed by 524.37% to $505.0 million in 2023, then grew by 8.71% to $549.0 million in 2024, then increased by 28.78% to $707.0 million in 2025.
  • Per Business Quant, the three most recent readings for CAH's EBITDA are $707.0 million (Q4 2025), $668.0 million (Q3 2025), and $428.0 million (Q2 2025).